Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.3K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-specific differences and diagnostic tool performance in the neuropsychiatric profile of Parkinson's disease.

BMC neurology·2026
Same author

Taiwan Clinical Practice Guidelines for Myasthenia Gravis.

Acta neurologica Taiwanica·2026
Same author

Unilateral Cortical Ribboning and Corticomedullary Lesions in a Rare Case of Coexisting Anti-N-methyl-D-aspartate Receptor Encephalitis and Neuronal Intranuclear Inclusion Disease.

Acta neurologica Taiwanica·2026
Same author

Preliminary evaluation of a fractal-based collateral biomarker for thrombectomy candidate selection in acute ischemic stroke: a retrospective study.

PeerJ·2026
Same author

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Neuroprotective Effects of Glucosamine in Huntington's Disease Through NLRP3 Inflammasome Inhibition.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology·2025

Related Experiment Video

Updated: Apr 20, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.5K

Biomarkers for neuromyelitis optica.

Kuo-Hsuan Chang1, Long-Sun Ro1, Rong-Kuo Lyu1

  • 1Department of Neurology, Chang Gung Memorial Hospital, Linkou Medical Center and College of Medicine, Chang-Gung University, Taoyuan, Taiwan.

Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 3, 2014
PubMed
Summary

Neuromyelitis optica (NMO) is an inflammatory disorder. New biomarkers like anti-aquaporin 4 (anti-AQP4) antibodies, IL-6, and glial fibrillary acidic protein (GFAP) aid NMO diagnosis and treatment strategies.

Keywords:
Anti-AQP4 antibodyAstrocytopathyBiomarkerNeuromyelitis opticaTh17

More Related Videos

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

1.5K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K
High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.9K

Area of Science:

  • Neuroimmunology
  • Autoimmune Disorders

Background:

  • Neuromyelitis optica (NMO) is a rare, inflammatory autoimmune disease affecting the optic nerves and spinal cord.
  • Characterized by optic neuritis and longitudinally extensive spinal cord lesions, NMO pathogenesis is increasingly understood through biomarkers.

Purpose of the Study:

  • To review current biomarker research in NMO.
  • To discuss the diagnostic and therapeutic potential of identified biomarkers.

Main Methods:

  • Review of scientific literature on NMO biomarkers.
  • Analysis of studies investigating anti-aquaporin 4 (anti-AQP4) antibodies, IL-6, and glial fibrillary acidic protein (GFAP).

Main Results:

  • The discovery of anti-aquaporin 4 (anti-AQP4) antibodies has transformed NMO understanding.
  • Candidate biomarkers, including IL-6 and GFAP, are linked to T helper 17 cell responses and astrocytic damage, correlating with disease activity.
  • IL-6 is associated with anti-AQP4 antibody production, while GFAP in cerebrospinal fluid (CSF) correlates with relapse severity.

Conclusions:

  • Biomarker detection is crucial for NMO diagnosis and monitoring disease activity.
  • Targeting these biomarkers offers promising avenues for novel NMO therapeutic strategies.